AUS
NZ
UK
CA
USA
IND
Highlights
Lithium Universe advances with key acquisition in photovoltaic recycling technology.
Surefire Resources intersects sulphides at Yidby Gold Project.
St George Mining begins new geophysical work at Brazilian rare earths project.
Lithium Universe Ltd ASX:LU7 has completed legal due diligence for its acquisition of New Age Minerals Pty Ltd, which holds exclusive rights to commercialise a novel Microwave Joule Heating Technology developed at Macquarie University. The technology is focused on solar panel recycling, an emerging segment in the renewable energy materials supply chain. The company plans to proceed with formal completion of the acquisition, aimed at enhancing its strategic footprint in clean energy solutions.
Surefire Resources uncovers sulphide zones at Yidby
Surefire Resources NL ASX:SRN has reported significant intersections of sulphide mineralisation in its ongoing drilling campaign at the Yidby Gold Project in Western Australia. The reverse circulation drilling, concentrated on the Marshall and Fender prospects, has returned continuous intersections of sulphides within quartz porphyry zones. These findings indicate extended mineralised structures that could support future resource definition activities.
St George Mining expands exploration at Araxá project
St George Mining Ltd ASX:SGQ has initiated a new geophysical phase at its Araxá Niobium and Rare Earth Elements Project in Brazil. The program includes high-resolution magnetic and seismic surveys, aiming to refine structural mapping and mineralisation zones. This follows previous drilling which confirmed high-grade assays of rare earth and niobium elements. The company intends to use these results to enhance the current drilling strategy across the site.
Rapid Critical Metals divests US tin asset
Rapid Critical Metals Ltd ASX:RCM has agreed to sell its Tin Mountain property in South Dakota to a subsidiary of IRIS Metals Ltd ASX:IR1. The property spans a large area of federally held mining claims and marks a strategic shift in the company’s focus. The divestment enables both parties to realign their resources within the metals and exploration sectors.
Prescient Therapeutics opens Share Purchase Plan
Prescient Therapeutics Ltd ASX:PTX has launched a Share Purchase Plan to raise funds for ongoing Phase 2 clinical development of PTX-100, a targeted therapy for Cutaneous T-Cell Lymphoma. The offer is available to eligible shareholders and will support operational and regulatory milestones linked to the company’s oncology pipeline.
Orthocell strengthens executive team
Orthocell Ltd ASX:OCC has announced the appointment of Jim Piper and Adam Wood as chief financial officer and chief commercial officer, respectively. The pair joins the company as it scales its international commercialisation of Remplir™, a nerve repair product. OCC is targeting key global healthcare markets, with a particular focus on accelerating sales and commercial partnerships in the United States.
